BB Biotech Balance Sheet Health
Financial Health criteria checks 5/6
BB Biotech has a total shareholder equity of CHF2.5B and total debt of CHF344.7M, which brings its debt-to-equity ratio to 13.9%. Its total assets and total liabilities are CHF2.8B and CHF354.0M respectively. BB Biotech's EBIT is CHF237.5M making its interest coverage ratio 38.8. It has cash and short-term investments of CHF2.8B.
Key information
13.9%
Debt to equity ratio
CHF344.70m
Debt
Interest coverage ratio | 38.8x |
Cash | CHF2.82b |
Equity | CHF2.47b |
Total liabilities | CHF353.99m |
Total assets | CHF2.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BION's short term assets (CHF2.8B) exceed its short term liabilities (CHF354.0M).
Long Term Liabilities: BION has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BION has more cash than its total debt.
Reducing Debt: BION's debt to equity ratio has increased from 10.4% to 13.9% over the past 5 years.
Debt Coverage: BION's debt is well covered by operating cash flow (25.1%).
Interest Coverage: BION's interest payments on its debt are well covered by EBIT (38.8x coverage).